Try a new search

Format these results:

Searched for:

person:luntzm01

Total Results:

55


Trabeculotomy-trabeculectomy for early-onset glaucoma [Comment]

Luntz MH
PMID: 10768320
ISSN: 0161-6420
CID: 24287

Use of viscoelastics post-trabeculectomy: a survey of members of the American Glaucoma Society

Salvo EC Jr; Luntz MH; Medow NB
BACKGROUND AND OBJECTIVE: American Glaucoma Society members were surveyed to determine the pattern of use of viscoelastics for anterior chamber reformation at the slit-lamp in the post-operative clinical management of patients who have undergone trabeculectomy in order to give ophthalmologists an indication of how these materials are being used by their colleagues. MATERIALS AND METHODS: We surveyed 196 members of the American Glaucoma Society regarding the following; (1) whether they inject viscoelastic post-operatively at the slit-lamp as an in-office procedure, (2) the type of viscoelastic used most often, (3) the criteria for injection of viscoelastic, (4) the time to first follow-up, (5) the average number of injections, and (6) the occurrence of post-injection endophthalmitis. RESULTS: One hundred twenty-five (64%) of the 196 mailed surveys were answered and returned. Ninety-four (75%) of the respondents reported injecting viscoelastics in the postoperative period at the slit-lamp as an in-office procedure. Healon (60%) (Pharmacia & Upjohn Co, Kalamazoo, MI), Viscoat (17%) (Alcon, Ft. Worth, TX), and Healon GV (7%) (Pharmacia & Upjohn Co, Kalamazoo, MI) were the three most often used viscoelastics. Hypotony, iriscornea touch, and lens-cornea touch were given as criteria for injection 19%, 47%, and 88% of the time, respectively. Range of time to first follow-up was 1 hour to 7 days, with a mean time of 1 day. Range of average number of injections was 1 to 3 with a mean of 2 injections for patients requiring injection. Only one respondent reported an incidence of endophthalmitis. CONCLUSIONS: The use of viscoelastic materials in the postoperative trabeculectomy patient in the office at the slit-lamp for anterior chamber reformation is a prevalent practice. Healon is the most commonly used viscoelastic postoperatively and lens-corneal touch is the most common criterion for injection. The average number of injections is 2, with a mean and mode follow-up time of 1 day. Endophthalmitis is a rare complication
PMID: 10219030
ISSN: 1082-3069
CID: 24288

Subconjunctival THC:YAG laser sclerostomy under a partial thickness flap

Luntz MH; Fliegler RD; Mastrobattista J
Holmium laser sclerostomy is a useful surgical procedure in eyes with refractory glaucoma. The success rate is 60%, comparable to the success rate with a seton, but there is a significantly lower rate of complications compared to a seton. Furthermore, the conjunctiva is minimally dissected and less surgical trauma is involved with the procedure, an advantage compared to other filtering operations. The use of a corneascleral flap producing a 'guarded' Holmium sclerostomy reduces the incidence of complications and there were no flat or shallow anterior chambers in the 47 eyes operated on and reviewed in this study
PMID: 8908432
ISSN: 1120-6721
CID: 24289

Trabeculectomy: a modified surgical technique

Luntz MH; Schlossman A
A modified surgical technique is described for trabeculectomy using contemporary limbal incisional techniques for a simplified dissection of the lamellar scleral flap, a technically easier operation, with smoothly dissected surfaces. The results and complications are comparable to those using the standard method
PMID: 8064615
ISSN: 0886-3350
CID: 22899

Subconjunctival THC:YAG laser sclerostomy under a partial-thickness corneal flap

Fliegler RJ; Mastrobattista J; Luntz MH
To evaluate the safety and effectiveness of THC:YAG laser sclerostomy in reducing intraocular pressure (IOP), we performed 16 subconjunctival sclerostomies under a partial-thickness corneal flap. We report the 3- and 6-month follow-up results in these patients, all of whom had intractable glaucoma resistant to previous surgical treatment. The mean IOP decreased from a pretreatment value of 30 mm Hg to a posttreatment value of 14 mm Hg at 3 months. Fifty-seven percent of the treated eyes achieved an IOP below 20 mm Hg at 6 months. A significant reduction in glaucoma medications is also reported among the successes. Complications were minimal
PMID: 8152729
ISSN: 0022-023x
CID: 24290

The choice of surgical procedure in congenital, infantile, and juvenile glaucoma

Luntz MH
1. Trabeculotomy is successful in patients with an angle anomaly involving only the trabecular meshwork, but in those involving the trabecular meshwork with iris or cornea, trabeculotomy combined with trabeculectomy is recommended. 2. In cases of failed trabeculotomy or trabeculectomy, a Molteno implant can be tried, although it does not work well in patients with congenital glaucoma. 3. If all else fails, a cyclodestructive procedure is indicated and contact Nd:YAG laser cyclophotocoagulation is recommended
PMID: 1996473
ISSN: 0194-5181
CID: 24291

Serum antibody levels to bovine corneal protein and polymethylmethacrylate intraocular lens after implantation

Kong AS; Luntz MH; Henley WL; Lubkin VL
PMID: 1936433
ISSN: 0250-3751
CID: 24292

The choice of surgical procedure in congenital, infantile, and juvenile glaucoma

Luntz MH
Trabeculotomy is successful in patients with an angle anomaly involving only the trabecular meshwork, but in those involving the trabecular meshwork with iris and/or cornea trabeculotomy combined with trabeculectomy is recommended. In cases of failed trabeculotomy or trabeculectomy, a Molteno implant can be tried, although it does not work well in patients with congenital glaucoma. If all else fails, a cyclodestructive procedure is indicated and contact Nd:YAG laser cyclophotocoagulation is recommended
PMID: 2366246
ISSN: 0744-7132
CID: 24293

Longitudinal study of serum antibody response to bovine corneal protein (BCP 54) in Behcet's disease

Kong AS; Henley WL; Luntz MH
Serum samples from a patient diagnosed as having active Behcet's syndrome with iritis were evaluated by the enzyme-linked immunosorbent assay for antibodies against a purified bovine corneal protein, molecular weight 54,000 daltons (BCP 54). Significantly elevated antibody levels to BCP 54 were found in all serum samples collected over a 2-year period. Anti-BCP 54 antibody levels remained within a very narrow range, at least twofold higher than those of controls. In contrast, no antibody to retinal S antigen was detected. These results indicate the presence of specific anti-BCP 54 autoantibodies in sera from a Behcet's patient and suggest that autoantibodies may play a role in the etiopathogenesis of uveitis
PMID: 2626237
ISSN: 0030-3747
CID: 24294

Limbal- vs fornix-based conjunctival trabeculectomy flaps [Letter]

Luntz MH
PMID: 3337187
ISSN: 0002-9394
CID: 24295